Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbisko Therapeutics Co., Ltd.

http://www.abbisko.com/

Latest From Abbisko Therapeutics Co., Ltd.

Asia Deal Watch: Nippon Shinyaku Acquires US Rights To Capricor’s DMD Drug

Plus deals involving Aculys/Neurelis, Xtalpi/Excelra, Abbisko/Lilly, Daiichi Sankyo/Cosette, Mitsubishi Tanabe/ADC Therapeutics and PersonGen/Transgene.

Deals Asia Pacific

Evotec Adds To Spate Of Metabolic Deals With Lilly Collaboration

The German biotech inks its fifth metabolic disease collaboration as it teams up with US major Lilly to develop kidney disease and diabetes assets.

Deals Metabolic Disorders

Two Chinese IPOs Kickstart A Hectic Biotech Fundraising Season

Two IPOs and 12 venture capital and private equity deals in China raised a combined $1bn in a hectic few weeks of October.

China Financing

Shanghai Kick-Starts New Consortium To Develop First-In-Class Cancer Drugs

A concerted effort to mobilize the pharma industry, research organizations and state-backed healthcare venture capital firms is under way in Shanghai.

China Financing
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register